[Smeglutide or its association with suicide and depression? A study points to the safety of weight loss drugs] On Tuesday (August 20), a new study published in the top medical journal found that after diabetes patients and obese patients took Semeglutide, a commonly used GLP-1 drug, they seemed more likely to report depression and suicidal tendencies than patients taking other drugs.